Systemic AL amyloidosis: current approach and future direction.
Bou Zerdan M, Nasr L, Khalid F, Allam S, Bouferraa Y, Batool S, Tayyeb M, Adroja S, Mammadii M, Anwer F, Raza S, Chaulagain CP.
Bou Zerdan M, et al.
Oncotarget. 2023 Apr 26;14:384-394. doi: 10.18632/oncotarget.28415.
Oncotarget. 2023.
PMID: 37185672
Free PMC article.
Review.
Systemic Light chain (AL) amyloidosis is a monoclonal plasma cell proliferative disorder characterized by deposition of amyloidogenic monoclonal light chain fragments causing organ dysfunction. ...While it is widely accepted that the pati …
Systemic Light chain (AL) amyloidosis is a monoclonal plasma cell proliferative disorder characterized by deposi …